Czechia· CZ-0222256
TRUMENBA
A meningokokkus b, multikomponenten-impfstoff product containing neisseria meningitidis group b fhbp protein subfamily a + neisseria meningitidis group b fhbp protein subfamily b, registered in Czechia by Pfizer Europe MA EEIG, Bruxelles. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY A + NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY B
- Manufacturer
- Pfizer Europe MA EEIG, Bruxelles
- Country
- Czechia (CZ)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e82d94e7-0db9-4aeb-8d3c-04a1c3345285 GET /v1/drugs/e82d94e7-0db9-4aeb-8d3c-04a1c3345285?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "5X0,5ML I",
"substance": "NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY A + NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY B",
"cz_kod_sukl": "0222256",
"product_type": "IM/BT",
"substance_codes": "21431,21432",
"registration_state": "R",
"registration_number": "EU/1/17/1187/003"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.